Chronic Lymphocytic Leukemia

Our oncologists, hematologists, and pathologists use advanced diagnostic tools and the latest treatments to manage chronic lymphocytic leukemia, a cancer of the blood and bone marrow that typically progresses slowly. Our specialists provide ongoing monitoring, care, and support to help you live with this chronic disease. We can also determine whether you can be monitored and delay treatment safely, or if you need to start tailored regimens of chemotherapy and newly approved targeted therapy to manage the condition.

Clinical Trials and Research Studies

Phase 5

A Phase 1/2 Open-label Study Investigating the Safety Tolerability and Efficacy of ASP7517 in subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Learn More

Phase 2

A PHASE IB-II STUDY OF HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE BORTEZOMIB AND ABATACEPT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

Learn More

Phase 3

A Phase 3 Randomized Multicenter Double-Blind Placebo-Controlled Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Learn More

Phase 1

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Learn More